Background Patients with type 2 diabetes mellitus are usually treated with oral antidiabetic agents but it is still not known whether these drugs have antioxidant effects in humans. Methods We studied 60 patients with type 2 diabetes mellitus, divided into three groups on the basis of hypoglycaemic treatment (Group A: metformin, Group B: glibenclamide, Group C: diet), All patients were followed for at least I year. The three subgroups had similar clinical characteristics. Twenty healthy subjects, of comparable sex and age, were enrolled as controls. In each subject, platelet production of superoxide anion (O-2(-)) elicited by collagen, was determined by lucigenin assay. Results Patients with diabetes had higher platelet O-2(-) production than controls; no correlation was observed between blood glucose and platelet production similar to that O-2(-) production. Group A patients had platelet O-2(-) of healthy subjects but lower than Group B and Group C patients. Conclusion The present findings suggest an in vivo antioxidant activity of metformin and warrant prospective studies to further explore this hypothesis. Copyright (C) 2002 John Wiley Sons, Ltd.

Metformin decreases platetet superoxide anion production in diabetic patients / Gargiulo, Patrizia; D., Caccese; Pignatelli, Pasquale; C., Brufani; F., De Vito; R., Marino; R., Lauro; Violi, Francesco; U., Di Mario; V., Sanguigni. - In: DIABETES/METABOLISM RESEARCH AND REVIEWS. - ISSN 1520-7552. - 18:2(2002), pp. 156-159. [10.1002/dmrr.282]

Metformin decreases platetet superoxide anion production in diabetic patients

GARGIULO, Patrizia;PIGNATELLI, Pasquale;VIOLI, Francesco;
2002

Abstract

Background Patients with type 2 diabetes mellitus are usually treated with oral antidiabetic agents but it is still not known whether these drugs have antioxidant effects in humans. Methods We studied 60 patients with type 2 diabetes mellitus, divided into three groups on the basis of hypoglycaemic treatment (Group A: metformin, Group B: glibenclamide, Group C: diet), All patients were followed for at least I year. The three subgroups had similar clinical characteristics. Twenty healthy subjects, of comparable sex and age, were enrolled as controls. In each subject, platelet production of superoxide anion (O-2(-)) elicited by collagen, was determined by lucigenin assay. Results Patients with diabetes had higher platelet O-2(-) production than controls; no correlation was observed between blood glucose and platelet production similar to that O-2(-) production. Group A patients had platelet O-2(-) of healthy subjects but lower than Group B and Group C patients. Conclusion The present findings suggest an in vivo antioxidant activity of metformin and warrant prospective studies to further explore this hypothesis. Copyright (C) 2002 John Wiley Sons, Ltd.
2002
antioxidant activity; metformin; platelets; superoxide anion; type 2 diabetes
01 Pubblicazione su rivista::01a Articolo in rivista
Metformin decreases platetet superoxide anion production in diabetic patients / Gargiulo, Patrizia; D., Caccese; Pignatelli, Pasquale; C., Brufani; F., De Vito; R., Marino; R., Lauro; Violi, Francesco; U., Di Mario; V., Sanguigni. - In: DIABETES/METABOLISM RESEARCH AND REVIEWS. - ISSN 1520-7552. - 18:2(2002), pp. 156-159. [10.1002/dmrr.282]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/248663
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 49
social impact